In an exciting advancement for the field of biotech, Novelty Nobility Inc. has successfully raised $16,800,000 in a fresh funding round aimed at propelling its innovative research into novel angiogenesis targets. Headquartered in Pangyo, South Korea, and Boston, Massachusetts, the company specializes in developing antibody-based therapeutics for critical areas in ophthalmology and oncology, where the process of angiogenesis has been identified as a key contributor to disease progression. This latest funding infusion underscores the confidence investors have in Novelty Nobility's mission of creating groundbreaking therapies that address unmet medical needs. The funds will be strategically utilized to advance the company鈥檚 research initiatives, enabling the pursuit of novel scientific discoveries while adhering to their core principle of "Noble Management." As articulated in their tagline, the intersection of groundbreaking scientific research and responsible leadership is at the heart of what Novelty Nobility stands for鈥攁n ethos most vividly represented in their emblem, which encapsulates the birth of new pharmaceutical solutions through innovative science. With this significant capital, Novelty Nobility Inc. is poised to enhance its research capabilities, advance clinical trials, and ultimately contribute to the transformation of treatment methodologies in the fields they serve. The promise of their work could pave the way for more effective therapies that change lives, reaffirming their commitment to creating a healthier future driven by innovation and integrity.
Novelty Nobility Secures $16.8 Million in Funding for Innovative Biotech Research in Ophthalmology and Oncology
Recently funded 路 $16.8MBiotechnology
Get the full Novelty Nobility company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
